 |
N-(4-Methoxyphenyl)-N,2,6-trimethylfuro[2,3-d] pyrimidin-4-amine |
|---|---|
| Trade Name | |
| Orphan Indication | Glioma |
| USA Market Approval | USA |
| USA Designation Date | 2016-02-18 00:00:00 |
| Sponsor | Flag Therapeutics, Inc.;9168 Wooden Road;Raleigh, North Carolina, 27617 |
Related Access Program